Valuation: DexCom, Inc.

Capitalization 25.89B 21.98B 20.57B 19.28B 35.58B 2,353B 39B 240B 92.69B 1,106B 97.09B 95.07B 4,007B P/E ratio 2025 *
32.1x
P/E ratio 2026 * 27.4x
Enterprise value 26.06B 22.13B 20.7B 19.41B 35.82B 2,369B 39.26B 242B 93.31B 1,113B 97.74B 95.71B 4,034B EV / Sales 2025 *
5.61x
EV / Sales 2026 * 4.89x
Free-Float
95.22%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.97%
1 week+0.06%
Current month+4.57%
1 month+14.31%
3 months-13.30%
6 months-20.04%
Current year-14.66%
More quotes
1 week 65.2
Extreme 65.2
69.77
1 month 58.14
Extreme 58.14
69.77
Current year 54.11
Extreme 54.11
93.25
1 year 54.11
Extreme 54.11
93.25
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
More quotes
Manager TitleAgeSince
Chief Executive Officer 46 2025-09-13
Director of Finance/CFO 45 2021-03-18
Chief Tech/Sci/R&D Officer 48 2022-09-30
Director TitleAgeSince
Director/Board Member 66 2009-11-19
Director/Board Member 63 2013-11-06
Chairman 65 2025-09-13
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.97%+0.06%-13.14%-42.10% 25.64B
-1.25%+4.63%+12.64%+18.66% 223B
-0.86%-1.91%+20.12%+27.37% 126B
-2.45%+1.31%+48.69%+104.88% 67.96B
-1.85%+4.01%-13.70%-21.29% 57.11B
-1.12%+0.04%+17.95%+74.71% 52.41B
-0.41%-1.65%+19.90%+38.25% 24.94B
+0.48%+0.10%+8.69%-31.46% 23.72B
-0.24%-1.01%-24.51%+18.80% 21.76B
-0.95%-1.86%+8.75%-3.43% 20.51B
Average -0.76%+0.19%+8.54%+18.44% 64.38B
Weighted average by Cap. -1.11%+1.54%+13.74%+26.28%
See all sector performances

Financials

2025 *2026 *
Net sales 4.64B 3.94B 3.69B 3.46B 6.38B 422B 7B 43.1B 16.63B 198B 17.42B 17.06B 719B 5.23B 4.44B 4.16B 3.9B 7.19B 476B 7.88B 48.55B 18.73B 223B 19.62B 19.21B 810B
Net income 831M 706M 660M 619M 1.14B 75.57B 1.25B 7.71B 2.98B 35.5B 3.12B 3.05B 129B 989M 840M 786M 737M 1.36B 89.95B 1.49B 9.18B 3.54B 42.26B 3.71B 3.63B 153B
Net Debt 174M 148M 139M 130M 240M 15.85B 263M 1.62B 624M 7.45B 654M 640M 26.99B -322M -274M -256M -240M -443M -29.3B -486M -2.99B -1.15B -13.77B -1.21B -1.18B -49.9B
More financial data * Estimated data
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.7% of net sales.
Employees
10,250
More about the company
Date Price Change Volume
25-12-16 66.37 $ +0.97% 4,591,463
25-12-15 65.73 $ -1.84% 7,428,659
25-12-12 66.96 $ -2.87% 6,833,025
25-12-11 68.94 $ +2.04% 6,926,610
25-12-10 67.56 $ +1.85% 8,527,643

Delayed Quote Nasdaq, December 16, 2025 at 04:00 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
66.37USD
Average target price
85.27USD
Spread / Average Target
+28.48%
Consensus

Quarterly revenue - Rate of surprise